Nearly one in five civil monetary penalty settlements related to Emergency Medical Treatment and Labor Act (EMTALA) violations involved psychiatric emergencies. That is the conclusion of a study to be published in the May ...
May 13, 2019
0
1
More than 400 cases against opioid manufacturers, distributors, and pharmacies are pending before a single federal judge, with the potential to net billions to address the crisis. But winning those suits would only be the ...
Mar 27, 2018
0
1
EpiPen maker Mylan has finalized a $465 million government agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade—charges brought after rival Sanofi filed a whistleblower ...
Aug 17, 2017
0
0
Johnson & Johnson has reached a $33 million settlement with 42 states, resolving allegations the health care giant sold numerous nonprescription medicines that didn't meet federal quality requirements for a couple of years.
May 24, 2017
0
0
Mylan will pay $465 million to resolve accusations from some regulators that it overbilled the federal Medicaid program for the EpiPen allergy medication, the drugmaker announced Friday.
Oct 7, 2016
0
5
The maker of a prescription fish-oil drug says it has reached a legal settlement that will allow it to promote unapproved uses of its drug for lowering fat levels.
Mar 8, 2016
0
1
Federal officials are ordering the recall of nearly 2,800 machines used to disinfect medical scopes. They blamed company violations that could lead to infections in patients.
Nov 13, 2015
0
11
Top Japanese drugmaker Takeda Pharmaceutical on Wednesday warned of its first annual loss in more than six decades after agreeing to pay around $2.4 billion to settle lawsuits over its Actos diabetes drug, amid cancer claims.
Apr 29, 2015
0
4
A $100 million settlement involving NuvaRing, a birth-control device linked to sometimes-fatal side effects, will stand now that enough claimants have chosen to opt into the agreement.
Jun 5, 2014
0
0
German pharmaceuticals maker Boehringer Ingelheim said Wednesday it has agreed to pay $650 million to settle around 4,000 lawsuits relating to its blood-thinning drug Pradaxa.
May 28, 2014
0
0
